Path2’s upstream production, midstream liquefaction and storage technologies paired with MPI’s European EPC and project ...
Two University of California, Santa Cruz, professors are recipients of the campus’s Innovation Catalyst grants, providing crucial support to bridging the gap between foundational research and ...
Dual immunotherapy in liver-cancer: Following the significant effects of the ‘dual immunotherapy’, the new combination treatment has been approved from the FDA, EMA and NMPA for previously untreated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results